Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Comparison of natural language processing versus International Classification of Diseases coding for skin cancer subtype identification from pathology reports.
Journal: Journal of the American Academy of Dermatology
Published: January 05, 2026
Interferon-gamma-inducible protein 30 prevents IFN-γ-receptor 1 degradation to maintain PD-L1 and MHC-II levels in metastatic melanoma.
Journal: Cell communication and signaling : CCS
Published: September 16, 2025
Structural changes from wild-type define tumor-rejecting neoantigens.
Journal: Journal for immunotherapy of cancer
Published: September 15, 2025
MHC class II on melanoma cells regulates the anti-tumor T cell response.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: July 28, 2025
Immunoediting restricts clonal neoantigens in primary, treatment-naive human tumors.
Journal: Immunity
Published: July 02, 2025
Towards a transcriptomic biomarker for the classification of melanocytic neoplasms.
Journal: PLoS genetics
Published: February 09, 2025
HCV- and HBV-mediated liver cancer converge on similar transcriptomic landscapes and immune profiles.
Journal: bioRxiv : the preprint server for biology
Published: July 15, 2024
Tumor immune microenvironment permissive to metastatic progression of ING4-deficient breast cancer.
Journal: PloS one
Published: May 06, 2024
Distinct sets of molecular characteristics define tumor-rejecting neoantigens.
Journal: bioRxiv : the preprint server for biology
Published: February 26, 2024
Evaluation of dermatologic diagnostic ability on skin of colour in preclinical medical students.
Journal: Skin health and disease
Published: February 04, 2024
Major histocompatibility complex class II in the tumor microenvironment: functions of nonprofessional antigen-presenting cells.
Journal: Current opinion in immunology
Published: December 15, 2022
Last Updated: 09/26/2026